Company Information

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE3644.8578.3 (+2.2 %)
PREV CLOSE ( ) 3566.55
OPEN PRICE ( ) 3566.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 660
TODAY'S LOW / HIGH ( )3528.00 3668.15
52 WK LOW / HIGH ( )1262.55 4338
NSE3646.8072.35 (+2.02 %)
PREV CLOSE( ) 3574.45
OPEN PRICE ( ) 3616.00
BID PRICE (QTY) 3646.80 (30)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 32166
TODAY'S LOW / HIGH( ) 3522.00 3674.00
52 WK LOW / HIGH ( )1260.75 4340
ChairmanDavuluri Rama Mohan Rao
Managing DirectorDavuluri Saharsh Rao
Company SecretarySarada Bhamidipati
Vice ChairmanDavuluri Sucheth Rao
Non Executive Independent DirectorHumayun Dhanrajgir
Parampally Vasudeva Maiya
Bharati Rao
Nirmala Murthy
Homi Rustam Khusrokhan
Prasad Raghava Menon
Non Independent & Non Executive DirectorChristopher M Cimarusti
Incorporation Year : 07-01 1984

Registered Office :

Address : 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills Hyderabad,
Telangana-500033 .

Phone : 040-67611600 / 67611700

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.